Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma
Jason Yongsheng Chan, Jing Quan Lim, Joe Yeong, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 5833-5846
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)
Michael J. Wagner, Megan Othus, Sandip Pravin Patel, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002990-e002990
Open Access | Times Cited: 112
Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade glioma
Anahita Fathi Kazerooni, Adam Kraya, Komal S. Rathi, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Multiomics characterization of breast angiosarcoma from an Asian cohort reveals enrichment for angiogenesis signaling pathway and tumor-infiltrating macrophages
Tun Kiat Ko, Zexi Guo, Bavani Kannan, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis
Andrea P. Espejo-Freire, Andrew Elliott, Andrew E. Rosenberg, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4816-4816
Open Access | Times Cited: 42
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
Evan Rosenbaum, Cristina R. Antonescu, Shaleigh Smith, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004149-e004149
Open Access | Times Cited: 37
Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma
Jui Wan Loh, Jing Yi Lee, Abner Herbert Lim, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 17
miR-497 target gene regulatory network in angiosarcoma
Annaleigh Benton, Noah M. Moriarty, Emma Terwilliger, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 9, pp. 879-890
Closed Access | Times Cited: 7
LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis
Wensu Wei, Ning Wang, Minhua Deng, et al.
Redox Biology (2021) Vol. 48, pp. 102201-102201
Open Access | Times Cited: 36
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
Vinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Cancer (2022) Vol. 128, Iss. 18, pp. 3383-3391
Closed Access | Times Cited: 25
Cutaneous angiosarcoma: A review of current evidence for treatment with checkpoint inhibitors
Lucy Guan, Marisa Palmeri, Roman Groisberg
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 14
Tumor-Infiltrating Mast Cells in Angiosarcoma Correlate With Immuno-Oncology Pathways and Adverse Clinical Outcomes
Sarah Tai, Elizabeth Chun Yong Lee, Boon Yee Lim, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 3, pp. 100323-100323
Closed Access | Times Cited: 5
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past
Vaia Florou, Breelyn A. Wilky
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 7
Closed Access | Times Cited: 31
Combined VEGFR and MAPK pathway inhibition in angiosarcoma
Michael J. Wagner, Yasmin A. Lyons, Jean Siedel, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Cutaneous Angiosarcomas: Molecular Pathogenesis Guides Novel Therapeutic Approaches
Lea V. Goerdt, Stefan W. Schneider, Nina Booken
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 429-443
Open Access | Times Cited: 21
The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy
Jing Yi Lee, Bavani Kannan, Boon Yee Lim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7839-7839
Open Access | Times Cited: 19
DeepRisk network: an AI-based tool for digital pathology signature and treatment responsiveness of gastric cancer using whole-slide images
Meng‐Xin Tian, Yao Zhao, Yufu Zhou, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic Expansion
Jong Hyuk Kim, Ashley J. Schulte, Aaron L. Sarver, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 4
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
Marcella Tazzari, Laura Bergamaschi, Alessandro De Vita, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7518-7518
Open Access | Times Cited: 26
Clinical and Molecular Insights of Radiation-Induced Breast Sarcomas: Is There Hope on the Horizon for Effective Treatment of This Aggressive Disease?
Stefania Kokkali, José Durán, Jerzy Klijanienko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4125-4125
Open Access | Times Cited: 17
Clinician's primer for soft tissue sarcomas: Nuances of histologic subtypes
Amy J. Wisdom, Chandrajit P. Raut, Candace L. Haddox, et al.
Cancer (2025) Vol. 131, Iss. 5
Closed Access
Angiosarcoma: Role of Immunotherapy
Tom Wei‐Wu Chen
Current Treatment Options in Oncology (2025)
Closed Access
Advancing Precision Medicine: The Role of Genetic Testing and Sequencing Technologies in Identifying Biological Markers for Rare Cancers
Joviana Farhat, Lara Alzyoud, Mohammad Alwahsh, et al.
Cancer Medicine (2025) Vol. 14, Iss. 8
Open Access
Case Report: A novel chemotherapy-free regimen combined with photodynamic therapy, target therapy, and immunotherapy in a geriatric male with huge recurrent scalp and facial angiosarcoma: a report of an extremely rare case and literature review
Ewetse Paul Maswikiti, Zedong Feng, Zhenyu Yin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions
Jong Hyuk Kim, Kate Megquier, Rachael Thomas, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 5, pp. 847-861
Open Access | Times Cited: 22
Recurrent PTBP1::MAML2 fusions in composite hemangioendothelioma with neuroendocrine differentiation: A report of two cases involving neck lymph nodes
Josephine K. Dermawan, William H. Westra, Cristina R. Antonescu
Genes Chromosomes and Cancer (2021) Vol. 61, Iss. 4, pp. 187-193
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top